Skip to content

Clinical evaluation of a perio gel to be used as an adjunct therapy to standard routine scaling in patients with moderate to severe periodontal disease

Clinical evaluation of a perio gel to be used as an adjunct therapy to standard routine scaling in patients with moderate to severe periodontal disease

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
DRKS
Registry ID
DRKS00011229
Enrollment
60
Registered
2016-11-04
Start date
2016-09-09
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Periodontal disease K05.6

Interventions

Group 1: standard routine scaling at baseline (in-office treatment) Group 2: standard routine scaling with adjunct perio gel treatment at baseline (in-office treatment)

Sponsors

Colgate-Palmolive Europe
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: signed informed consent form; male/female; good general health, periodontal conditions

Exclusion criteria

Exclusion criteria: orthodontics applicances; tumors; participation in any other trial; pregnant/lactating women

Design outcomes

Primary

MeasureTime frame
change in periodontal attachement level at 6 months. The attachment level is determined by measuring the distance between the pocket depth and a fixed reference point on the tooth (cemento-enamel junction).

Secondary

MeasureTime frame
over time change in pocket depth, bleeding probing, and plaque

Countries

Italy, United Kingdom

Contacts

Public ContactPhilip Preshaw

University of Newcastle

philip.preshaw@newcastle.ac.uk0044-191-282-1170

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 15, 2026